Target Sciences, GlaxoSmithKline R&D, 1250 South Collegeville Road, Collegeville, PA 19426, USA.
Platform Technology & Science, GlaxoSmithKline R&D, Gunnels Wood Road, Stevenage, SG1 2NY, UK.
J Biotechnol. 2018 Oct 20;284:91-101. doi: 10.1016/j.jbiotec.2018.08.007. Epub 2018 Aug 22.
The CRISPR/Cas9 system has enabled efficient modification of genes in a variety of cellular systems for studying phenotypic effects of genetic perturbations. However, with this technology comes the inherent risk of generating off-target effects (OTEs) in addition to the desired modifications. As such, it can be difficult to conclusively determine that the observed phenotypic changes are in fact due to the intended modification of the target gene and not from random mutations elsewhere in the genome. In addition, biological variations observed within cultured cells or laboratory animals can also confound results and need to be addressed. In this article, we review potential sources of experimental and biological variation as well as propose experimental options to minimize and control OTEs and other variations in CRISPR genome editing experiments for exploratory research applications. Confirmation of on-target KO effect by orthogonal approaches is also discussed.
CRISPR/Cas9 系统已可用于在各种细胞系统中高效修饰基因,从而研究遗传扰动的表型效应。然而,这项技术除了能实现预期的修饰外,还存在产生脱靶效应(off-target effects,OTEs)的固有风险。因此,很难确定观察到的表型变化实际上是由于靶基因的预期修饰,而不是由于基因组其他部位的随机突变所致。此外,在培养细胞或实验动物中观察到的生物学变异也会使结果复杂化,需要加以解决。本文综述了 CRISPR 基因组编辑实验中潜在的实验和生物学变异来源,并提出了一些实验方案来最小化和控制 OTEs 及其他变异,以用于探索性研究应用。我们还讨论了通过正交方法确认靶基因敲除(knockout,KO)效应的方法。